Risk
GOT Issues: An Update
Earlier this year, I wrote an article for Carrier Management that looked at potentially emerging issues that may have not yet been captured on the risk monitors of underwriters or by the algorithms ...
More Emerging Risks for 2021: Insurance Costs for Violence Unclear
When I wrote about emerging issues facing the property/casualty insurance industry for Carrier Management early in 2020 I stated, "Insurers and reinsurers face numerous emerging issues arising from: ...
Middle Market Businesses Represent Untapped Telematics Opportunity: Nationwide Survey
Most middle market business owners are more interested in vehicle telematics insurance products than their agents realize, a dynamic that reveals a significant opportunity to sell the technology more ...
Biodiversity Loss Among ‘Very Top Risks’, Warns AXA Executive
AXA Group's chief risk and investment officer, Alban de Mailly Nesle is required to ponder myriad dangers to the Paris-based insurer and its 830 billion-euro ($995 billion) asset management arm. He ...
The 2020 Atlantic Hurricane Season Was One for the Record Books
A record-setting Atlantic hurricane season that saw the highest number of named storms officially came to a close Monday. The National Oceanic and Atmospheric Administration said the 2020 Atlantic ...
U.S. States Reportedly Plan to Sue Facebook Over Alleged Antitrust Violations
A group of U.S. states led by New York is investigating Facebook Inc for possible antitrust violations and plans to file a lawsuit against the social media giant next week, four sources familiar with ...
UK-Based Reinsurer Conduit Holdings Sees Stock Rise After $1.1B London IPO
Reinsurer Conduit Holdings Ltd. rose as it started trading in London after a 826 million-pound ($1.1 billion) initial public offering, the second largest by a British company on the London Stock ...
Legal, Cultural Backlash Likely to Prevent U.S. Employers From Mandating COVID-19 Vaccine
Private U.S. companies have the right under the law to require employees to get vaccinated against COVID-19, but are unlikely to do so because of the risks of legal and cultural backlash, experts ...

